Legally Effective but Ethically Inadequate: Institutional Review Board Policies for Consent from Legally Authorized Representatives

Q2 Social Sciences Ethics & human research Pub Date : 2023-03-27 DOI:10.1002/eahr.500158
Robert R. Harrison
{"title":"Legally Effective but Ethically Inadequate: Institutional Review Board Policies for Consent from Legally Authorized Representatives","authors":"Robert R. Harrison","doi":"10.1002/eahr.500158","DOIUrl":null,"url":null,"abstract":"<div>\n \n <p>The prevailing approach to enrolling decisionally impaired adults in clinical research is to rely on permission from a default surrogate, one identified by law rather than by the prospective research participant. Reliance on a surrogate transfers the focus of ethical protection from a researcher-participant relationship to a researcher-surrogate relationship; the selection and role of the surrogate are therefore important. The Common Rule defers to state law governing default surrogate consent to research, but most states have no such law; for those states, the Common Rule defers to institutional policy. I reviewed twenty-five of the study sites with the highest National Institutes of Health funding levels to elaborate the content of institutional review board (IRB) policies and compare those to a suggested paradigm for ethically defensible policies. My findings suggest that IRB policies provide inadequate protection because they recognize surrogates who lack knowledge of the subject's current values and preferences without imposing adequate additional safeguards.</p>\n </div>","PeriodicalId":36829,"journal":{"name":"Ethics & human research","volume":"45 2","pages":"14-25"},"PeriodicalIF":0.0000,"publicationDate":"2023-03-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Ethics & human research","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/eahr.500158","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"Social Sciences","Score":null,"Total":0}
引用次数: 0

Abstract

The prevailing approach to enrolling decisionally impaired adults in clinical research is to rely on permission from a default surrogate, one identified by law rather than by the prospective research participant. Reliance on a surrogate transfers the focus of ethical protection from a researcher-participant relationship to a researcher-surrogate relationship; the selection and role of the surrogate are therefore important. The Common Rule defers to state law governing default surrogate consent to research, but most states have no such law; for those states, the Common Rule defers to institutional policy. I reviewed twenty-five of the study sites with the highest National Institutes of Health funding levels to elaborate the content of institutional review board (IRB) policies and compare those to a suggested paradigm for ethically defensible policies. My findings suggest that IRB policies provide inadequate protection because they recognize surrogates who lack knowledge of the subject's current values and preferences without imposing adequate additional safeguards.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
法律上有效,但道德上不充分:机构审查委员会的政策,从合法授权的代表同意
将决策障碍成年人纳入临床研究的主流方法是依赖默认代理人的许可,该代理人是由法律而非潜在研究参与者确定的。对代理人的依赖将伦理保护的重点从研究者-参与者关系转移到研究者-代理人关系;因此,代理的选择和作用非常重要。《共同规则》遵循州法律,规定研究的默认代理同意,但大多数州都没有这样的法律;对这些州来说,共同规则服从于制度政策。我审查了美国国立卫生研究院资金水平最高的25个研究点,以详细阐述机构审查委员会(IRB)政策的内容,并将其与道德辩护政策的建议范式进行比较。我的研究结果表明,IRB政策提供的保护不足,因为它们承认代孕者对受试者当前的价值观和偏好缺乏了解,而没有施加足够的额外保障。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Ethics & human research
Ethics & human research Social Sciences-Health (social science)
CiteScore
2.90
自引率
0.00%
发文量
35
期刊最新文献
Issue Information The Prospect of Artificial Intelligence-Supported Ethics Review Ethical Issues Faced by Data Monitoring Committees: Results from an Exploratory Qualitative Study The Ethical Case for Decentralized Clinical Trials The European Health Data Space as a Case Study
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1